UltraQuant Assay SARS-CoV-2 Quantification V1 (RUO)

REF 162A

Description

The UltraQuant Assay SARS-CoV-2 Quantification V1 (RUO) is a  real time RT-PCR test  intended to quantification of  SARS-CoV-2 genome  using extracted RNA from already diagnosed positive patients to SARSCoV-2.

 

Methodology

Reverse Transcriptase Polymerase Chain Reaction (RT-PCR).

The test targets the N gene of the SARS-CoV-2, including regions that harbor mutations of interest described as sufficient, when present to identify variants of concern (VOC).

Intended user

The product  is intended to be used by trained clinical laboratory personnel specifically instructed and trained in the techniques of RT-PCR .

Complementary information

More information on Ultragene Assays – Click here

Intended Use (RUO)

The UltraQuant Assay SARS-CoV-2 Quantification V1 is a  RT-PCR test amplifying the N gene of the SARS-CoV-2 for Quantification .

 

 

Characteristics and performances

Ordering information

Downloads

General Documentation

  • 162A Leaflet

    EN

    V1

Request Documentation

Email address
Assay Serial Number